Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy of Somatropin will be evaluated in short children born with a list weight
below 1500 g and that did not catch up to normal height at the age of 4.